Firm Advises Warburg Pincus in Acquisition of JHP Pharmaceuticals

January 3, 2013

An affiliate of Warburg Pincus LLC acquires JHP Pharmaceuticals, LLC, a fully integrated specialty pharmaceutical company, from JHP Holdings, LLC for $195 million.

On December 31, it was announced that an affiliate of Willkie client Warburg Pincus LLC has acquired JHP Pharmaceuticals, LLC, a fully integrated specialty pharmaceutical company, from JHP Holdings, LLC, an entity majority-owned by Morgan Stanley Principal Investments, for $195 million on a debt-free, cash-free basis. JHP's current management team will continue to hold an interest in the company. Headquartered in New Jersey, JHP acquires, develops, manufactures and sells sterile injectable products. The company has over 370 employees in the U.S. in its manufacturing, product development, sales & marketing and corporate areas. With more than $30 billion in assets under management, Warburg Pincus is a leading global private equity firm focused on growth investing.

The deal was handled by partners Steven Gartner, Robert Langdon, Hillel Jacobson and Jordan Messinger; of counsel William Thomas; and associates Brandon Ladoff, Tej Prakash, Nicholas Cirella, Evan Goodman, Johanna Hickman, DJ Stauber, Amir Ghavi, Toby Lewis, Adam Feit and Edward Dix.